FAQs

According to the requirement of the test, three negative controls should be set to check the contamination. We can make one negative control, one blank control with water, and an environmental sample control in the whole batch of specimens so as to meet the requirements of the three controls.

It is recommended to inactivate specimens by water bath or dry bath (oven) at 56℃ for 30-45 minutes. In case of dry bath, the inactivation time for heating specimens to 56℃ can be extended appropriately (by testing the time needed for heating the same volume of normal saline to 56℃). According to our observation, inactivation has little impact on the subsequent test result.

Its name is RNase P (ribonuclease P). RNase P is ubiquitous in all organs, tissues and cells of the human body, and it can be detected from RNA fragments of human specimens. Meanwhile, it can also be used as an internal standard, and monitor the accuracy of the whole experimental operation process.

Bio-Rad CFX96, Hongshi SLAN96, AGS4800, Agilent Mx3000p and Mx3005P can be used for the 2019-nCoV RNA detection kit from DaAn. ABI7300plus and Q3 cannot be used for 2019-nCoV reagents of DaAn Gene due to the lack of CY5 channel. Theoretically, instruments with the three channels (FAM, VIC(HEX) and CY5) can be used for 2019-nCoV reagents of DaAn Gene, and those that fail to meet the requirements cannot be used for 2019-nCoV reagents of DaAn Gene.

There are column extraction method, paramagnetic particle method and one-step extraction method for RNA virus extraction. The paramagnetic particle method and column extraction method can be divided into manual operation and automatic machine operation. Generally, original liquid specimens are taken for extraction. The automatic paramagnetic particle extraction is characterized to be the best effect, with the advantages such as safe and convenient operation, large extraction amount for one time, high extraction efficiency and the best subsequent amplification effect. Therefore, it is recommended to use the paramagnetic particle method with an automatic machine to extract 2019-nCoV nucleic acid for the subsequent PCR amplification experiment. The specific instrument and magnetic particle reagent are with reference to the instructions of each manufacturer.

In the "test principle" of the instructions, target genes corresponding to three channels are introduced. N gene probe is labeled with FAM, ORF1ab gene is labeled with Yellow fluorescence, and can be tested with VIC passage, so the description of channel in result interpretation is VIC channel. The internal standard gene probe is labeled with Cy5.

As RNA virus, 2019-nCoV is easily degraded, and the test results are also related to sampling, nucleic acid extraction and the nucleic acid concentration of the specimens, so all of these factors need to be analyzed one by one. Meanwhile, the results can be interpreted in combination with clinical symptoms.

If there is no internal standard tested in the specimen by using 2019-nCoV reagents of Daan Gene, the specimen must be reviewed. It can be remixed to extract nucleic acid. If there is still no internal standard tested by 2019-nCoV reagents of Daan Gene, the specimen is unqualified when there is no extraction problem, and the clinical re-sampling and review shall be notified.

Reasons for false negative: No suitable specimens were collected in different courses of disease; viruses from collected specimens were not enough to be detected; it is not sensitive enough for the test reagent; the nucleic acid extraction is not efficient. False positive: There are cross contamination during nucleic acid extraction and PCR products contamination; it is also related to specimen type and sampling method. Broncho-alveolar lavage fluid is better than swabs and can be collected simultaneously with nasopharyngeal swabs.

The real-time fluorescent RT-PCR test results of 2 targets (ORF1ab and N) of 2019-nCoV in the same specimens are tested as positive. If there is a positive test result for a single target, it needs to be re-sampled and re-tested.

This technology uses DNA amplification and membrane hybridization technique. The probe is immobilized onto nitrocellulose membrane or nylon membrane respectively. Each probe is blotted and numbered. The primer is labeled with a biotin at the 5’ end in advance, so the DNA samples are labeled with biotin by specific DNA amplification. The probe hybrid with the DNA samples to test and show hybridization signal after corresponding reaction.

A. Analyze multiple sites at the same time.
(1) A number of different probes are spotted in one membrane at the same time.
(2) RDB technique can detect a variety of different genotypes simultaneously.
(3) RDB technique can simultaneously detect multiple mutations in a gene.
B. High sensitivity and specificity.
(1) PCR amplification of target genes improve the sensitivity.
(2) Many specific probes increase specificity.

Yes. Our specific designed Taqman probe can screen for the single point mutation, gene frame-shift mutation, deletion mutation, gene translocation, heterozygous alleles, and wild type on the same allele sequence.

Yes. It has melting curve analysis which can be used to discriminate target PCR product and by-product.

A. qPCR is performed in a closed-tube system, avoiding a false positive due to PCR product contamination.

B. Quantitative detection of genes extends the scope of clinical application.

C. Spectroscopy has further improved sensitivity.

D. Fluorescent probe hybridization has further improved the specificity.

E. The integration of amplification and automatic assay makes the detection more convenient and quick.

A. Diagnosis at an early stage.
B. Monitoring the therapeutic effect of drug.
C. Tracking the cause of illness.
D. The epidemiological investigation.
E. Serological typing can classify the individual risk potentially and determine treatment options.

A. Diagnosis of infectious disease.
B. Control and observation of mother-to-child transmission.
C. Diagnosis of genetic disease.
D. Diagnosis of tumor.
E. Identification of forensic medicine.